Mavens Biotech Ltd. - Research Center
590083 MAVENSBIO Group (XT) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 16 |
Mar ' 16 |
Sep ' 15 |
Sep ' 14 |
Sep ' 13 |
Sales |
0.56 |
0.41 |
0.42 |
0.43 |
21.66 |
Operating profit |
0.07 |
0.13 |
0.14 |
0.11 |
0.29 |
Interest |
- |
- |
- |
- |
- |
Gross profit |
0.07 |
0.13 |
0.14 |
0.16 |
0.34 |
EPS (Rs) |
- |
0.01 |
0.01 |
0.01 |
0.02 |
Half yearly
results in details
|
Sep ' 16 |
Mar ' 16 |
Sep ' 15 |
Sep ' 14 |
Sep ' 13 |
Other income |
- |
- |
- |
0.05 |
0.05 |
Stock adjustment |
0.22 |
- |
- |
- |
0.04 |
Raw material |
- |
- |
- |
- |
- |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
0.11 |
0.11 |
0.11 |
0.12 |
0.11 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
0.08 |
- |
- |
- |
Other expenses |
0.16 |
0.09 |
0.17 |
0.20 |
21.22 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.05 |
0.07 |
0.07 |
0.09 |
0.11 |
Taxation |
- |
- |
- |
- |
- |
Net profit / loss |
0.02 |
0.06 |
0.06 |
0.07 |
0.23 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
10.99 |
10.99 |
10.99 |
10.99 |
10.99 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
747.00 |
747.00 |
747.00 |
Agg.of non promotoholding (%) |
- |
- |
67.96 |
67.96 |
67.96 |
OPM (%) |
12.42 |
32.37 |
32.72 |
25.05 |
1.33 |
GPM (%) |
- |
- |
- |
33.33 |
1.57 |
NPM (%) |
- |
- |
- |
15.43 |
1.07 |